在骨质疏松症中对部结构和机械参数产生特里巴拉提德,德诺苏马布和索莱德酸的差异影响; 一项现实研究
N Jaarah1,2, C F J Lam1,2, N Lodhia1,2
1Department of Chemical Pathology and Metabolic Medicine, St Thomas' Hospital, 5Th Floor, North Wing, Lambeth Palace Road, London, UK.
Journal of endocrinological investigation
|January 9, 2024
概括
特里巴拉提德,德诺苏马布和佐莱德龙酸治疗改善了骨质疏松症患者的部几何学. 部结构参数的这些变化有助于解释这些疗法的抗骨折效应.
科学领域:
- 整形外科 整形外科 整形外科
- 类风湿病学 类风湿病学
- 老年病的医生 老年病的医生
- 放射学 放射学是一门学科.
背景情况:
- 骨质疏松症 (OP) 是一种骨疾病,其特点是骨强度受损,骨折风险增加.
- 有效的OP管理包括治疗不仅增加骨矿物质密度,而且改善骨结构完整性.
研究的目的:
- 为了评估 teriparatide (TPD),denosumab (Dmab) 和 zoledronate (ZOL) 对部几何参数在现实临床环境中的影响.
- 了解这些骨质疏松症治疗方法的抗骨折功效背后的机制.
主要方法:
- 249名骨质疏松症患者 (平均年龄为71.5岁) 的队列被分为三组,接受TPD,Dmab或ZOL.
- 骨矿物质密度 (BMD) 在基线和随访时使用DXA进行评估.
- 部结构分析 (HSA) 在DXA大腿部图像上进行了回顾性分析,以评估狭窄部 (NN),间 (IT) 和大腿骨轴 (FS) 的参数.
主要成果:
- 泰里巴提德 (TPD) 治疗导致截面面积 (CSA) 和截面惯性矩 (CSMI) 在窄部 (NN) 显著增加.
- 德诺苏马布 (Dmab) 治疗显示,关节间 (IT) 的多个部结构参数得到改善,包括CSA,皮质厚度,CSMI,截面模量 (Z) 和曲率 (BR).
- 索莱德酸盐 (ZOL) 治疗也表明,关节 (IT) 和狭 (NN) 的部几何状况发生了积极的变化,CSA,CSMI和Z的显著增加.
结论:
- 对特里巴拉提德,德诺苏马布和佐莱德罗纳特的现实世界分析揭示了它们对部几何学的明显影响.
- 部结构参数的改善有助于这些骨质疏松症治疗的抗骨折效果.
- 部几何分析为OP治疗的疗效提供了宝贵的见解,超出了BMD测量.
更多相关视频
07:52Author Spotlight: Enhancing Small Animal Bone Compression Testing for Research
Published on: December 1, 2023
1.7K
04:24Proper Positioning and Restraint of a Rat Hind Limb for Focused High Resolution Imaging of Bone Micro-architecture Using In Vivo Micro-computed Tomography
Published on: November 22, 2017
9.9K
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
